by The Tutu Team | Apr 6, 2017 | Uncategorized
Source: Breast Cancer Research Foundation Science News CDK4/6 inhibitors are a new class of drugs that have shown promise in the treatment of advanced ER- positive breast cancer. Cyclin dependent kinases (CDK) regulate the process of cell division, required for... 